These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34543281)

  • 1. The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
    Guida F; Tan VY; Corbin LJ; Smith-Byrne K; Alcala K; Langenberg C; Stewart ID; Butterworth AS; Surendran P; Achaintre D; Adamski J; Amiano P; Bergmann MM; Bull CJ; Dahm CC; Gicquiau A; Giles GG; Gunter MJ; Haller T; Langhammer A; Larose TL; Ljungberg B; Metspalu A; Milne RL; Muller DC; Nøst TH; Pettersen Sørgjerd E; Prehn C; Riboli E; Rinaldi S; Rothwell JA; Scalbert A; Schmidt JA; Severi G; Sieri S; Vermeulen R; Vincent EE; Waldenberger M; Timpson NJ; Johansson M
    PLoS Med; 2021 Sep; 18(9):e1003786. PubMed ID: 34543281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.
    Bull CJ; Bell JA; Murphy N; Sanderson E; Davey Smith G; Timpson NJ; Banbury BL; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Burnett-Hartman A; Casey G; Castellví-Bel S; Chan AT; Chang-Claude J; Cross AJ; de la Chapelle A; Figueiredo JC; Gallinger SJ; Gapstur SM; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Joshu CE; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; May AM; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Phipps AI; Platz EA; Potter JD; Qu C; Quirós JR; Rennert G; Riboli E; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Tsilidis KK; Ulrich CM; van Duijnhoven FJB; van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Wang H; White E; Wolk A; Woods MO; Wu AH; Campbell PT; Zheng W; Peters U; Vincent EE; Gunter MJ
    BMC Med; 2020 Dec; 18(1):396. PubMed ID: 33327948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
    Carayol M; Leitzmann MF; Ferrari P; Zamora-Ros R; Achaintre D; Stepien M; Schmidt JA; Travis RC; Overvad K; Tjønneland A; Hansen L; Kaaks R; Kühn T; Boeing H; Bachlechner U; Trichopoulou A; Bamia C; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Quirós JR; Sánchez-Cantalejo E; Huerta JM; Ardanaz E; Arriola L; Agudo A; Nilsson J; Melander O; Bueno-de-Mesquita B; Peeters PH; Wareham N; Khaw KT; Jenab M; Key TJ; Scalbert A; Rinaldi S
    J Proteome Res; 2017 Sep; 16(9):3137-3146. PubMed ID: 28758405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of circulating metabolites and breast cancer in EPIC.
    His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
    BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.
    Shu X; Wu L; Khankari NK; Shu XO; Wang TJ; Michailidou K; Bolla MK; Wang Q; Dennis J; Milne RL; Schmidt MK; Pharoah PDP; Andrulis IL; Hunter DJ; Simard J; Easton DF; Zheng W;
    Int J Epidemiol; 2019 Jun; 48(3):795-806. PubMed ID: 30277539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
    PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
    Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
    Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases.
    Pang Y; Kartsonaki C; Lv J; Fairhurst-Hunter Z; Millwood IY; Yu C; Guo Y; Chen Y; Bian Z; Yang L; Chen J; Clarke R; Walters RG; Holmes MV; Li L; Chen Z
    JAMA Cardiol; 2021 Mar; 6(3):276-286. PubMed ID: 33263724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study.
    Vithayathil M; Carter P; Kar S; Mason AM; Burgess S; Larsson SC
    PLoS Med; 2021 Jul; 18(7):e1003706. PubMed ID: 34324486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
    Kliemann N; Viallon V; Murphy N; Beeken RJ; Rothwell JA; Rinaldi S; Assi N; van Roekel EH; Schmidt JA; Borch KB; Agnoli C; Rosendahl AH; Sartor H; Huerta JM; Tjønneland A; Halkjær J; Bueno-de-Mesquita B; Gicquiau A; Achaintre D; Aleksandrova K; Schulze MB; Heath AK; Tsilidis KK; Masala G; Panico S; Kaaks R; Fortner RT; Van Guelpen B; Dossus L; Scalbert A; Keun HC; Travis RC; Jenab M; Johansson M; Ferrari P; Gunter MJ
    BMC Med; 2021 Apr; 19(1):101. PubMed ID: 33926456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
    BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.
    Assi N; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen HC; Sundkvist A; Kühn T; Travis RC; Overvad K; Riboli E; Gunter MJ; Scalbert A; Jenab M; Ferrari P; Viallon V
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):531-540. PubMed ID: 29563134
    [No Abstract]   [Full Text] [Related]  

  • 15. Transgenerational cycle of obesity and diabetes: investigating possible metabolic precursors in cord blood from the PREOBE study.
    Shokry E; Marchioro L; Uhl O; Bermúdez MG; García-Santos JA; Segura MT; Campoy C; Koletzko B
    Acta Diabetol; 2019 Sep; 56(9):1073-1082. PubMed ID: 31062097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of General Adiposity and Central Body Fat Distribution on the Circulating Metabolome: A Multicohort Nontargeted Metabolomics Observational and Mendelian Randomization Study.
    Ahmad S; Hammar U; Kennedy B; Salihovic S; Ganna A; Lind L; Sundström J; Ärnlöv J; Berne C; Risérus U; Magnusson PKE; Larsson SC; Fall T
    Diabetes; 2022 Feb; 71(2):329-339. PubMed ID: 34785567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolome-wide Mendelian randomization for age at menarche and age at natural menopause.
    Yazdanpanah M; Yazdanpanah N; Gamache I; Ong K; Perry JRB; Manousaki D
    Genome Med; 2024 May; 16(1):69. PubMed ID: 38802955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations.
    Deng K; Gupta DK; Shu XO; Lipworth L; Zheng W; Cai H; Cai Q; Yu D
    Circ Genom Precis Med; 2024 Aug; 17(4):e004437. PubMed ID: 38950084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.
    Moore SC; Playdon MC; Sampson JN; Hoover RN; Trabert B; Matthews CE; Ziegler RG
    J Natl Cancer Inst; 2018 Jun; 110(6):588-597. PubMed ID: 29325144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
    Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
    Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.